High Content & Phenotypic Screening 2016

Date: Tuesday, 10 May 2016 - Wednesday, 11 May 2016
Location: Cambridge, UK

Keynote Speakers

Marc Bickle
Head of Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics

Beverley Isherwood
Associate Director & Head High Content Biology, Innovative Medicines, AstraZeneca

Neil Carragher
Principal Investigator, University of Edinburgh

Leo Price
CEO, Ocello B.V

Overview

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Agenda Topics

3D Cell Models
High Content Screening
Image Analysis and Data Management
Phenotypic Drug Discovery

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Paul Andrews, Director/Consultant, Stem Cell Solutions Ltd
Andreas Bender, Lecturer, The University of Cambridge
Darren Cawkill, Associate Director, Pfizer
Martin Daffertshofer, Director Strategic Marketing Imaging Informatics, Perkin Elmer Cellular Technologies GmbH
Thierry Dorval, Group Leader, Servier
Xavier Gidrol, Laboratory Director, CEA Grenoble
Catherine Goh, Head of Product Development and Marketing, siTOOLs Biotech GmbH
Marie-Edith Gourdel, Chemistry Director, Hybrigenics Services
Sheraz Gul, Head of Assay Development & Screening, Fraunhofer-IME SP
Maxime Mioulane, Field Application Scientist, Thermo Scientific
Maria Montoya, Head, National Center for Cardiovascular Research
Sebastian Munck, Bio Imaging Core Leader, KU Leuven
Matthias Nees, Group Leader, University of Turku
Christian Parker, Lab Head, Novartis Institute For Biomedical Research
Douglas Ross-Thriepland, Senior Scientist, Astrazeneca
Alan Sandercock, Scientist II, MedImmune
Steven Titus, Staff Scientist, NIH - NCATS
Andreas Traube, Head of Department, Laboratory Automation and Biomanufacturing Engineering Fraunhofer IPA

Corporate Sponsors	Media Sponsors	Web Partner	Networking

Add to Calendar ▼2016-05-10 00:00:002016-05-11 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2016High Content and Phenotypic Screening 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

#HCPS2016 Tweets

Corporate Sponsors